1991
DOI: 10.1001/archderm.1991.01680010079012
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous Manifestations of Multiple Myeloma

Abstract: We report the cutaneous manifestations of multiple myeloma, using a retrospective review of 115 patients' records obtained from tumor registry files. Five patients were found to have biopsy-proved extramedullary plasmacytomas without extension from an underlying bony focus. Twelve patients had ecchymoses without thrombocytopenia; two of them had biopsy-proved amyloidosis. One patient presented with pyoderma gangrenosum and was subsequently diagnosed with multiple myeloma. The last patient initially presented w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
28
0
3

Year Published

1993
1993
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(32 citation statements)
references
References 30 publications
1
28
0
3
Order By: Relevance
“…There are several lines of evidence supporting an immunologic etiology of PG. For one, as mentioned above, patients often have a coexisting immunemediated disease such as IBD or inflammatory arthritis (RA, ankylosing spondylitis, or other seronegative arthritis) (23)(24)(25)(26)(27)(28)(29)(30). Second, patients treated with immune modifying medications for other conditions rarely develop PG; for example, there have been separate case reports of patients developing PG in the setting of infliximab or granulocyte-macrophage colony-stimulating factor (GMCSF) therapy (31,32).…”
Section: Pathophysiologymentioning
confidence: 99%
“…There are several lines of evidence supporting an immunologic etiology of PG. For one, as mentioned above, patients often have a coexisting immunemediated disease such as IBD or inflammatory arthritis (RA, ankylosing spondylitis, or other seronegative arthritis) (23)(24)(25)(26)(27)(28)(29)(30). Second, patients treated with immune modifying medications for other conditions rarely develop PG; for example, there have been separate case reports of patients developing PG in the setting of infliximab or granulocyte-macrophage colony-stimulating factor (GMCSF) therapy (31,32).…”
Section: Pathophysiologymentioning
confidence: 99%
“…L'implication de nombreux médicaments a été rapportée, les facteurs de croissance granulocytaire étant les plus fréquemment incriminés [8]. L'apparition d'un syndrome de Sweet au cours de l'évolution spontanée d'un myélome multiple est rare, avec seulement deux cas rapportés dans la littérature [9,10] ; d'autres cas seraient secondaires à l'administration de facteurs de croissance granulocytaire [8,11]. Nous retenons chez notre patient le diagnostic de syndrome de Sweet, malgré l'absence de fièvre et d'hyperleucocytose, en raison de l'aspect clinique compatible et surtout de l'examen anatomopathologique tout à fait évocateur, montrant un derme oedémateux siège d'un infiltrat inflammatoire riche en polynucléaires neutrophiles.…”
Section: Discussionunclassified
“…The nonspecific manifestations include a cutaneous finding owing to the abnormal level of proteins (amyloid, cryoglobulins), cytopenia (anemia, thrombocytopenia, and leukopenia), and involvement of internal organs (kidney, lungs, nerves, and ganglion). Since Bluefarb's publication, other cutaneous manifestations of multiple myeloma have been described, including pyoderma gangrenosum, 4,5 leukocytoclastic vasculitis, Sweet's syndrome, subcorneal pustular dermatosis, POEMS ( p olyneuropathy, o rganomegaly, e ndocrinopathy, m onoclonal gammopathy, s kin changes) plane xanthoma, scleromyxedema, waldenström macroglobulinemia cutis, amyloidosis, and cryoglobulinemias 6–8 . Plasmacytoma is characterized by a proliferation of neoplastic plasma cells in the tissue.…”
Section: Discussionmentioning
confidence: 99%
“…Various cutaneous lesions have been associated with multiple myeloma. Fluefarb has classified them as specific lesions and nonspecific lesions 3,4 …”
Section: Introductionmentioning
confidence: 99%